Autopsy report · NCT05104840
A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus
Cause of deathFunding or business
“the company is liquidated”
Life of this trial
- Registered 9 months before it started.
- Ran for about 8 months before it stopped.
- 2,432 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Center Trials & Treatment
- Sponsor type
- University, hospital or other
- Conditions
- COVID-19; SARS-CoV-2; Furin; RGMc Processing; Paired Basic Amino Acid Cleaving Enzyme (PACE)
- Participants
- 2,432
- Sites
- 9
- Countries
- India, Ukraine, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.